만성 B형 간염에서 알파 인터페론 치료에 대한 반응과 B형 간염 바이러스 core 유전자 변이와의 상관 관계
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 유병철 | - |
dc.contributor.author | 김형준 | - |
dc.contributor.author | 도재혁 | - |
dc.contributor.author | 박실무 | - |
dc.date.accessioned | 2022-03-22T06:40:10Z | - |
dc.date.available | 2022-03-22T06:40:10Z | - |
dc.date.issued | 2002-11 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/55650 | - |
dc.format.extent | 8 | - |
dc.publisher | 대한간학회 | - |
dc.title | 만성 B형 간염에서 알파 인터페론 치료에 대한 반응과 B형 간염 바이러스 core 유전자 변이와의 상관 관계 | - |
dc.title.alternative | Relationship Between Core Gene Mutations of Hepatitis B Virus and Response to Alpha Interferon Therapy in Chronic Hepatitis B | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, v.8, no.2002, pp 381 - 388 | - |
dc.identifier.kciid | ART000860099 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 388 | - |
dc.citation.number | 2002 | - |
dc.citation.startPage | 381 | - |
dc.citation.title | Clinical and Molecular Hepatology | - |
dc.citation.volume | 8 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | 간염/바이러스성/만성 B형 간염 | - |
dc.subject.keywordAuthor | B형 간염바이러스 | - |
dc.subject.keywordAuthor | Core 유전자 변이 | - |
dc.subject.keywordAuthor | 알파 인터페론 | - |
dc.subject.keywordAuthor | Hepatitis/Viral/Chronic hepatitis B | - |
dc.subject.keywordAuthor | Hepatitis B virus | - |
dc.subject.keywordAuthor | Core gene mutation | - |
dc.subject.keywordAuthor | Alpha-interferon | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.